Stakeholders welcome 1 June listings

New Stories

• Immutep posts encouraging Phase 2 results as 'Efti' spurs robust anti-tumour activity

  November 13, 2025 - - Australian Biotech

• PYC Therapeutics appoints Peter Coleman as new Chair as part of board renewal

  November 13, 2025 - - Australian Biotech

• New gene discoveries improve diagnosis of inherited heart disease

  November 13, 2025 - - Australian Biotech

• Chimeric Therapeutics reports strong early results from CHM CDH17 Phase 1/2 trial

  November 13, 2025 - - Australian Biotech

• Australia joins global WHO task force to tackle antimicrobial resistance

  November 13, 2025 - - Latest News

• New post-market review workplan focuses on real-world data and patient outcomes

  November 13, 2025 - - Latest News

• Government adds new first-line treatment to the PBS for deadly blood cancer

  November 13, 2025 -